GLP-1 agonists exert anti-hypertensive effects compared to placebo [69], reducing systolic blood pressure by 23 mmHg
Description Product Information Product Name: Retatrutide (LY3437943), 99.70% purity peptide (TFA removed) Description: Retatrutide is the first triple agonist peptide targeting the Glucagon, GLP-1, and GIP receptors (3G) , the EC50 values are 5.79 nM, 0.0643 nM, and 0.775 nM respectively [1]
Thats a message that resonates in the C-suite
Both PKA inhibitors (Rp-cAMP and H-89) and PI3 kinase inhibitors (LY294002 and wortmannin) partially suppressed the anti-apoptotic effect of GLP-1 on MG-induced apoptosis in both INS-1 and MIN6 cells (Fig
n = 17)
PLoS ONE 8(7):e68743 Vargas-Franco D, Kalra R, Draper I, Pacak CA, Asakura A, Kang PB (2022) The Notch signaling pathway in skeletal muscle health and disease